Workflow
HBC(603077)
icon
Search documents
和邦生物(603077) - 首创证券股份有限公司关于上海证券交易所对四川和邦生物科技股份有限公司2024年年度报告的信息披露监管问询函的回复
2025-07-08 09:16
首创证券股份有限公司 关于上海证券交易所对四川和邦生物科技 股份有限公司 2024 年年度报告的信息披露监管问询函的 回复 保荐机构(主承销商) 创证券股份有限公 . SEC 2 问题 5: 关于在建工程。年报显示,公司在建工程期末余额 23.54 亿元,同 比增长 100.6%,本期购建固定资产、无形资产和其他长期资产支付的现金 11.16 亿元,应付票据期末余额 6.69亿元,同比增长 100.90%,系报告期内开立票据 支付材料、工程款增加所致。光伏项目方面,8GW 光伏封装材料及制品项目总 预算 30 亿元,本年度在建工程增加金额为 6.29 亿元,累计投入占预算比例仅从 2023 年末的 75.43%增长为 85.12%;半年报显示,10GWN+型超高效单晶太阳 能硅片项目工程累计投入占预算比例为 13.37%,公司称鉴于行业产能过剩将暂 停在光伏组件项目的投入,而年报未披露相关数据。 请公司补充披露:(1)结合 8GW 光伏封装材料及制品项目具体内容、建设 周期、预计完工期限、转固金额等,说明本期投资金额与累计投入占比不匹配 的原因及合理性,并结合项目建设规模、进度及市场情况、价格变化等说明本 期 ...
和邦生物(603077) - 四川华信(集团)会计师事务所(特殊普通合伙)关于上海证券交易所对四川和邦生物科技股份有限公司2024年年度报告的信息披露监管问询函的回复
2025-07-08 09:16
| 四川华信(集团)会计师事务所 | 地址:成都市洗面桥街 18 号金茂礼都南 28 楼 | | --- | --- | | (特殊普通合伙) | 电话:(028)85560449 传真:(028)85560449 | | | 邮编: 610041 | | SI CHUAN HUA XIN (GROUP) CPA (LLP) | 电邮: schxzhb@hxcpa.com.cn | 四川华信(集团)会计师事务所(特殊普通合伙) 关于上海证券交易所对四川和邦生物科技股份有限公司 2024 年年度报告的信息披露监管问询函的回复 川华信综 A(2025)第 0017 号 目录: 1、四川华信(集团)会计师事务所(特殊普通合伙)关于上海证券交易所对 四川和邦生物科技股份有限公司 2024 年年度报告的信息披露监管问询函 的回复 1 四川华信(集团)会计师事务所(特殊普通合伙) 关于上海证券交易所对四川和邦生物科技股份有限公司 公司回复: 2024 年年度报告的信息披露监管问询函的回复 川华信综 A(2025)第 0017 号 上海证券交易所: 我所作为四川和邦生物科技股份有限公司(以下简称 "和邦生物"或"公司") ...
和邦生物(603077) - 和邦生物关于上海证券交易所《关于四川和邦生物科技股份有限公司2024年年度报告的信息披露监管问询函》的回复公告(豁免版)
2025-07-08 09:15
| 证券代码:603077 | 证券简称:和邦生物 | 公告编号:2025-032 | | --- | --- | --- | | 债券代码:113691 | 债券简称:和邦转债 | | 四川和邦生物科技股份有限公司 关于上海证券交易所《关于四川和邦生物科技股份有 限公司 2024 年年度报告的信息披露监管问询函》的 回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 四川和邦生物科技股份有限公司(以下简称"公司")于近日收到上海证券 交易所上市公司监管一部下发的《关于四川和邦生物科技股份有限公司 2024 年 年度报告的信息披露监管问询函》(上证公函【2025】0869 号)(以下简称"《问 询函》")。公司对《问询函》高度重视,积极组织相关各方对《问询函》所提 问题进行认真核查,现就相关问题回复并公告如下: 一、关于矿业情况。年报披露,公司矿产品(包含盐矿和磷矿)营业收入 3.92 亿元,合计利润贡献超 1.89 亿元,为本期主要利润来源。截至报告披露日, 公司通过自有、投资、合作等方式,获得可开发的矿权共计 39 ...
加快绿色化工产业集群发展,推动产业链规模能级提升 发力4+N,广安攻坚千亿级
Si Chuan Ri Bao· 2025-07-03 02:36
Core Viewpoint - The development of a "4+N" industrial project framework in Guang'an aims to establish a billion-level green chemical industry cluster, led by four major projects with a total investment exceeding 50 billion yuan, generating an annual output value of over 100 billion yuan and tax revenue nearing 10 billion yuan upon completion [1] Group 1: Industrial Development - The four major projects, including Hebang, Lier, Chengxin, and Jiuyuan, are expected to drive the growth of multiple billion-level or near-billion-level projects [1] - Guang'an has set a goal to create a trillion-level green chemical industry cluster, transitioning from a focus on key industrial chain collaboration to becoming a primary carrier for industrial chain scale enhancement [1] Group 2: Technological Innovation - Companies in Guang'an are implementing technological upgrades to achieve green development, with projects like the second phase of Jingu Environmental Protection converting kitchen waste oil into biodiesel [2][3] - Guang'an Economic Development Zone collaborates with universities to support the establishment of R&D centers, resulting in 51 invention patents and 13 industry-leading products [3] Group 3: Project Management and Progress - A rapid feedback mechanism, including daily progress meetings, is employed to address production challenges and ensure timely project completion [4] - The Guang'an Economic Development Zone has implemented a multi-faceted approach to enhance project quality and efficiency, including a three-party joint office model for problem-solving [4] Group 4: Service and Infrastructure Support - Guang'an Economic Development Zone acts as a "chief service officer" for enterprises, addressing challenges such as power supply issues for projects like the Jatai Haifu Silicon-based Nano Materials project [5][6] - Infrastructure improvements in the New Bridge Chemical Park, including wastewater treatment facilities and transportation networks, have significantly enhanced the park's operational capabilities [6]
基础化工行业动态研究:草甘膦价格上涨,关注农药市场修复机会
Guohai Securities· 2025-07-02 15:39
Core Insights - The report maintains a "recommended" rating for the agricultural chemical industry, highlighting the recovery potential in the pesticide market due to rising glyphosate prices [1][8] - Glyphosate prices have shown a significant recovery, with the raw material price reaching 24,800 CNY per ton as of July 1, 2025, an increase of 1,800 CNY per ton since early April [6][8] Industry Performance - The basic chemical industry has outperformed the CSI 300 index over various time frames, with a 1-month performance of 5.0%, 3-month performance of 3.2%, and a 12-month performance of 16.4% compared to the CSI 300's 2.7%, 1.5%, and 13.6% respectively [4] Investment Highlights - The glyphosate industry is experiencing inventory depletion and demand recovery, leading to a price rebound from its bottom. As of June 27, 2025, glyphosate industry inventory was 40,000 tons, down 43,000 tons since early April [6] - The global largest glyphosate producer, Bayer, faces potential bankruptcy due to ongoing lawsuits related to its glyphosate product "Roundup," which could benefit domestic competitors in the glyphosate market [7] Company Focus - Key companies in the glyphosate sector include: - Jiangshan Chemical, with a production capacity of 70,000 tons/year [9] - Xingfa Group, the leading domestic glyphosate producer with a capacity of 230,000 tons/year [9] - Xin'an Chemical, with a capacity of 80,000 tons/year [10] - Yangnong Chemical, a major player with a capacity of 30,000 tons/year [10] - Guoxin Co., with a capacity of 20,000 tons/year [10] - Hebang Bio, with a capacity of 50,000 tons/year [10] - Lier Chemical, with a capacity of 18,500 tons/year [10] - Limin Co., with a capacity of 5,000 tons of glyphosate and 2,000 tons of refined glyphosate [10] Earnings Forecast - The report provides earnings per share (EPS) estimates for key companies, indicating potential growth in profitability: - Jiangshan Chemical: EPS of 1.10 CNY in 2025E [11] - Xingfa Group: EPS of 1.85 CNY in 2025E [11] - Yangnong Chemical: EPS of 3.44 CNY in 2025E [11] - Guoxin Co.: EPS of 1.12 CNY in 2025E [11] - Lier Chemical: EPS of 0.53 CNY in 2025E [11] - Limin Co.: EPS of 1.05 CNY in 2025E [11]
和邦生物: 和邦生物关于提供担保的进展公告
Zheng Quan Zhi Xing· 2025-07-01 16:30
Summary of Key Points Core Viewpoint - The company Sichuan Hebang Biological Technology Co., Ltd. has announced the provision of guarantees for its subsidiaries, Sichuan Wujun Photovoltaic Co., Ltd. and Wujun Chongqing Photovoltaic Co., Ltd., totaling RMB 33.4 million, which aligns with its strategic financial management and support for subsidiary projects [1][2][6]. Group 1: Guarantee Details - The total guarantee amount for Sichuan Wujun Photovoltaic Co., Ltd. is RMB 134 million, with a current guarantee balance of RMB 384 million [1][2]. - The total guarantee amount for Wujun Chongqing Photovoltaic Co., Ltd. is RMB 200 million, with a current guarantee balance of RMB 1,197.2065 million [1][2]. - Both guarantees are structured as joint liability guarantees, with no counter-guarantees in place [2][6]. Group 2: Internal Decision-Making Process - The company’s board of directors approved the guarantee provision during a meeting held on April 28, 2025, with a total authorized guarantee limit of RMB 6 billion for subsidiaries [2][6]. - The company has set specific limits for guarantees based on the subsidiaries' debt-to-asset ratios, with a maximum of RMB 1.2 billion for those above 70% and RMB 4.8 billion for those below [2][6]. Group 3: Financial Overview of Guaranteed Entities - Sichuan Wujun Photovoltaic Co., Ltd. has total assets of RMB 3.1 billion and a net profit of RMB -25.624 million for the first quarter of 2025 [3][5]. - Wujun Chongqing Photovoltaic Co., Ltd. is a wholly-owned subsidiary of Sichuan Wujun, with a registered capital of RMB 100 million and a focus on solar energy services and photovoltaic equipment manufacturing [3][4]. Group 4: Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary to support the subsidiaries' ongoing projects and align with the company's overall strategic interests [6]. - The company maintains control over the subsidiaries' operations and finances, which mitigates the associated risks of the guarantees [6]. Group 5: Cumulative Guarantee Situation - As of June 30, 2025, the total external guarantees provided by the company and its subsidiaries amount to RMB 8.049 billion, representing 43.21% of the company's latest audited net assets [6]. - There are no overdue guarantees or guarantees provided to controlling shareholders or related parties [6].
和邦生物(603077) - 和邦生物关于可转债转股结果暨股份变动公告
2025-07-01 10:33
证券代码:603077 证券简称:和邦生物 公告编号:2025-031 债券代码:113691 债券简称:和邦转债 四川和邦生物科技股份有限公司 关于可转债转股结果暨股份变动公告 ● 累计转股情况:截至 2025 年 6 月 30 日,四川和邦生物科技股份有限公 司(以下简称"公司"、"本公司")可转债"和邦转债"累计转股金额为 229,000 元,累计因转股形成的股份数量 114,500 股,占可转债转股前公司已发行股份总 额的 0.0013%。 ● 未转股可转债情况:截至 2025 年 6 月 30 日,尚未转股的"和邦转债" 金额为 4,599,771,000 元,占可转债发行总量的 99.9950%。 ● 本季度转股情况:"和邦转债"转股起始日为 2025 年 5 月 6 日,自 2025 年 5 月 6 日至 2025 年 6 月 30 日,"和邦转债"转股金额为 229,000 元,因转股 形成的股份数量为 114,500 股。 一、可转债发行上市概况 经中国证券监督管理委员会证监许可[2024]1233 号同意注册,公司于 2024 年 10 月 28 日向不特定对象发行了 4,600 万张可转 ...
和邦生物(603077) - 和邦生物关于提供担保的进展公告
2025-07-01 10:31
| 证券代码:603077 | 证券简称:和邦生物 | 公告编号:2025-030 | | --- | --- | --- | | 债券代码:113691 | 债券简称:和邦转债 | | 四川和邦生物科技股份有限公司 关于提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 担保对象及基本情况 | | 被担保人名称 | | 四川武骏光能股份有限公司 | | | --- | --- | --- | --- | --- | | | 本次担保金额 | 13,400.00 | 万元 | | | 担保对象一 | 实际为其提供的担保余额 | 38,400.00 | 万元 | | | | 是否在前期预计额度内 | 是 | □否 | □不适用:_________ | | | 本次担保是否有反担保 | □是 | 否 | □不适用:_________ | | 担保对象二 | 被担保人名称 | | 武骏重庆光能有限公司 | | | | 本次担保金额 | 20,000.00 | | 万元 | | | 实际为其提供的担 ...
和邦生物(603077) - 和邦生物关于控股股东可转债持有比例变动达到10%的公告
2025-06-27 10:48
| 证券代码:603077 | 证券简称:和邦生物 | 公告编号:2025-029 | | --- | --- | --- | | 债券代码:113691 | 债券简称:和邦转债 | | 四川和邦生物科技股份有限公司 关于控股股东可转债持有比例变动达到 10%的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、可转债配售情况 二、可转债的持有变动情况 2025 年 6 月 27 日,公司收到控股股东和邦集团的通知,自 2025 年 5 月 6 日至 2025 年 6 月 27 日,和邦集团通过上海证券交易所大宗交易及集中竞价交易 方式合计减持公司可转债 4,600,000 张,占公司可转债发行总量的比例为 10%。 具体变动情况如下: | | 本次转让前 | 本次转让前占 | | 本次转让 | 本次转让占发 | | 本次转让后 | 本次转让后占 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 持有人名称 | 持有数量 | 发行总量的 ...
低辐射玻璃(Low-E)概念涨0.64%,主力资金净流入这些股
Concept Performance - The PET copper foil concept saw a daily increase of 2.09%, while the combustible ice concept experienced a decline of 4.14% [1] - Other notable increases included photolithography at 1.45% and BC battery at 1.13%, while short drama games fell by 3.07% [1] Low-E Glass Concept - The Low-E glass concept had a net inflow of 0.45 billion yuan, with seven stocks receiving net inflows, led by Wanshun New Materials with 20.91 million yuan [1] - Key stocks in the Low-E glass concept included Wanshun New Materials, Hainan Development, and Qibin Group, with respective net inflows of 20.91 million yuan, 17.66 million yuan, and 13.23 million yuan [1] Stock Performance - As of June 20, the Low-E glass concept increased by 0.64%, ranking 10th among concept sectors, with Wanshun New Materials, Hainan Development, and Qibin Group leading the gains at 4.68%, 2.64%, and 1.62% respectively [3] - Decliners in the Low-E glass concept included XinSai Co., Sanxia New Materials, and AnCai High-Tech, with declines of 2.53%, 1.00%, and 0.22% respectively [3] Fund Flow Ratios - Fund inflow ratios were highest for Qibin Group, Wanshun New Materials, and Hainan Development, with net inflow rates of 11.05%, 7.29%, and 5.62% respectively [2][4] - Wanshun New Materials had a trading volume of 20.91 million yuan and a turnover rate of 7.81% [2]